MIAMI, Oct. 27, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that its positive long-term ...

Las Vegas researchers move toward phase two of clinical trial for hypoplastic left heart syndrome ...

For decades, it was impossible for clinicians to know which babies with major heart defects might eventually have developmental abnormalities, like ADHD and learning differences. Now, by adapting a ...

The family of an 8-year-old girl with a rare heart defect is using their journey to support other families in the same ...

The private placement was led by Coastlands Capital, with participation from Janus Henderson Investors, along with Logos Capital and Kalehua Capital, for total gross proceeds in the initial closing of ...

ORLANDO, Fla. (WKRC) - A local family is soaking up every minute with their 1-year-old son, who was recently admitted to hospice care. Xaiden Combs from Ripley was born with a heart condition known as ...

MIAMI, June 24, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (LGVN) (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and ...

Children's Hospital Colorado (Children's Colorado) successfully performed the hospital's first-ever heart and liver dual organ transplant, with support from dozens of team members across 25 different ...

The private placement is led by Coastlands Capital, with participation from Janus Henderson Investors, along with Logos Capital and Kalehua Capital, for total gross proceeds in the initial closing of ...